These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36786124)
1. Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England. Branford D; Sun JJ; Shankar R Br J Psychiatry; 2023 May; 222(5):191-195. PubMed ID: 36786124 [TBL] [Abstract][Full Text] [Related]
2. Patterns of antiseizure medications prescribing in people with intellectual disability and epilepsy: A narrative review and analysis. Branford D; Sun JJ; Burrows L; Shankar R Br J Clin Pharmacol; 2023 Jul; 89(7):2028-2038. PubMed ID: 37060156 [TBL] [Abstract][Full Text] [Related]
3. Antidepressant prescribing for adult people with an intellectual disability living in England. Branford D; Shankar R Br J Psychiatry; 2022 Aug; 221(2):488-493. PubMed ID: 35249557 [TBL] [Abstract][Full Text] [Related]
4. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451 [TBL] [Abstract][Full Text] [Related]
5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Deb S; Unwin G; Deb T J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study. Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687 [TBL] [Abstract][Full Text] [Related]
7. Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case-control study. Sun JJ; Watkins L; Henley W; Laugharne R; Angus-Leppan H; Sawhney I; Shahidi MM; Purandare K; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Perera B; Hyams B; Ashby S; Shankar R J Neurol; 2023 Jul; 270(7):3527-3536. PubMed ID: 37022478 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities. O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463 [TBL] [Abstract][Full Text] [Related]
9. Management of psychotropic medications in adults with intellectual disability: a scoping review. Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887 [TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions. Deutsch SI; Burket JA Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599 [TBL] [Abstract][Full Text] [Related]
11. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability]. de Kuijper G; Degraeve G; Zinkstok JR Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889 [TBL] [Abstract][Full Text] [Related]
12. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders. Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105 [TBL] [Abstract][Full Text] [Related]
13. The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA. McLaren JL; Lichtenstein JD Epidemiol Psychiatr Sci; 2019 Aug; 28(4):365-368. PubMed ID: 30353794 [TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication use in adolescents with intellectual disability living in the community. Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635 [TBL] [Abstract][Full Text] [Related]
15. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study. Song M; Ware R; Doan TN; Harley D J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300 [TBL] [Abstract][Full Text] [Related]
16. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. Branford D J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():577-86. PubMed ID: 7881229 [TBL] [Abstract][Full Text] [Related]
17. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review. Moon S; Watkins L; O'Dwyer M; Shankar R Expert Rev Neurother; 2024 Nov; 24(11):1097-1105. PubMed ID: 39160772 [TBL] [Abstract][Full Text] [Related]
18. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. Clarke DJ; Kelley S; Thinn K; Corbett JA J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549 [TBL] [Abstract][Full Text] [Related]
19. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities. McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691 [TBL] [Abstract][Full Text] [Related]
20. Psychotropic prescribing in people with intellectual disability and challenging behaviour. Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479 [No Abstract] [Full Text] [Related] [Next] [New Search]